- Home
- BOLD vs BNGO Comparison
BOLD vs BNGO Comparison
Compare BOLD & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- BNGO
- Stock Information
- Founded
- BOLD 2018
- BNGO 2003
- Country
- BOLD United States
- BNGO United States
- Employees
- BOLD N/A
- BNGO N/A
- Industry
- BOLD
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- BOLD
- BNGO Industrials
- Exchange
- BOLD Nasdaq
- BNGO Nasdaq
- Market Cap
- BOLD 30.3M
- BNGO 24.3M
- IPO Year
- BOLD 2024
- BNGO 2018
- Fundamental
- Price
- BOLD $1.42
- BNGO $4.05
- Analyst Decision
- BOLD Buy
- BNGO Buy
- Analyst Count
- BOLD 3
- BNGO 4
- Target Price
- BOLD $22.50
- BNGO $7.00
- AVG Volume (30 Days)
- BOLD 69.6K
- BNGO 216.7K
- Earning Date
- BOLD 05-12-2025
- BNGO 05-07-2025
- Dividend Yield
- BOLD N/A
- BNGO N/A
- EPS Growth
- BOLD N/A
- BNGO N/A
- EPS
- BOLD N/A
- BNGO N/A
- Revenue
- BOLD N/A
- BNGO $30,776,000.00
- Revenue This Year
- BOLD N/A
- BNGO $0.53
- Revenue Next Year
- BOLD N/A
- BNGO $8.46
- P/E Ratio
- BOLD N/A
- BNGO N/A
- Revenue Growth
- BOLD N/A
- BNGO N/A
- 52 Week Low
- BOLD $1.06
- BNGO $2.68
- 52 Week High
- BOLD $12.65
- BNGO $72.60
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- BNGO 52.17
- Support Level
- BOLD N/A
- BNGO $2.68
- Resistance Level
- BOLD N/A
- BNGO $5.22
- Average True Range (ATR)
- BOLD 0.00
- BNGO 0.50
- MACD
- BOLD 0.00
- BNGO 0.21
- Stochastic Oscillator
- BOLD 0.00
- BNGO 53.94
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.